Naxifylline

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNaxifylline
Drug Alias Name那昔茶碱naxifilinanaxifyllinumnaxifyllineCVT-124 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsAutoimmune DiseasesHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncBiogen IncUniversity Of Florida
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesHeart Failure

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG